Business · 13/10/2017

Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA) has released a draft guidance document outlining how it will assess user fees under the Prescription Drug User Fee Amendments of 2017, which were enacted in 2017. The guidance aims to clarify policies and procedures for applying these fees.